Qianhai Health Holdings Limited (HKG:0911)
Hong Kong · Delayed Price · Currency is HKD 0.7300
-0.0200 (-2.67%)
Jun 1, 2026, 3:45 PM HKT
Qianhai Health Holdings Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 677.12 | 519.7 | 961.29 | 1,962 | 283.4 | |
Revenue Growth (YoY) | 30.29% | -45.94% | -51.00% | 592.21% | -62.75% |
Cost of Revenue | 654.86 | 490.03 | 996.89 | 2,123 | 278.78 |
Gross Profit | 22.26 | 29.67 | -35.6 | -161.52 | 4.62 |
Selling, General & Admin | 14.04 | 15.49 | 16.75 | 19.36 | 20.67 |
Operating Expenses | 16.59 | 15.75 | 16.58 | 2.43 | 20.67 |
Operating Income | 5.67 | 13.92 | -52.18 | -163.95 | -16.06 |
Interest Expense | -0.04 | -0.02 | -0.04 | -0.03 | -0.51 |
Interest & Investment Income | 0.48 | 0.24 | 0.07 | 0.1 | 0.12 |
Currency Exchange Gain (Loss) | -0.17 | -0.18 | -1.55 | 1.07 | 1.26 |
Other Non Operating Income (Expenses) | - | -60.4 | 1 | -93.2 | - |
EBT Excluding Unusual Items | 5.94 | -46.44 | -52.71 | -256.01 | -15.18 |
Gain (Loss) on Sale of Assets | - | 51.9 | - | 21.95 | 14.3 |
Asset Writedown | - | -4.15 | - | - | - |
Other Unusual Items | - | - | - | 0.36 | - |
Pretax Income | 5.94 | 1.31 | -52.71 | -233.7 | -0.89 |
Income Tax Expense | 0 | - | - | - | - |
Earnings From Continuing Operations | 5.94 | 1.31 | -52.71 | -233.7 | -0.89 |
Net Income | 5.94 | 1.31 | -52.71 | -233.7 | -0.89 |
Net Income to Common | 5.94 | 1.31 | -52.71 | -233.7 | -0.89 |
Net Income Growth | 353.17% | - | - | - | - |
Shares Outstanding (Basic) | 169 | 169 | 169 | 169 | 169 |
Shares Outstanding (Diluted) | 169 | 169 | 169 | 169 | 169 |
Shares Change (YoY) | - | - | - | 0.08% | 0.01% |
EPS (Basic) | 0.04 | 0.01 | -0.31 | -1.38 | -0.01 |
EPS (Diluted) | 0.04 | 0.01 | -0.31 | -1.38 | -0.01 |
EPS Growth | 353.16% | - | - | - | - |
Free Cash Flow | - | 4.19 | 0.86 | -5.26 | -44.19 |
Free Cash Flow Per Share | - | 0.03 | 0.01 | -0.03 | -0.26 |
Gross Margin | 3.29% | 5.71% | -3.70% | -8.23% | 1.63% |
Operating Margin | 0.84% | 2.68% | -5.43% | -8.36% | -5.67% |
Profit Margin | 0.88% | 0.25% | -5.48% | -11.91% | -0.31% |
Free Cash Flow Margin | - | 0.81% | 0.09% | -0.27% | -15.59% |
EBITDA | 7.39 | 15.64 | -50.46 | -162.22 | -14.33 |
EBITDA Margin | 1.09% | 3.01% | -5.25% | -8.27% | -5.06% |
D&A For EBITDA | 1.72 | 1.72 | 1.72 | 1.72 | 1.73 |
EBIT | 5.67 | 13.92 | -52.18 | -163.95 | -16.06 |
EBIT Margin | 0.84% | 2.68% | -5.43% | -8.36% | -5.67% |
Effective Tax Rate | 0.03% | - | - | - | - |